Effective January 21, 2014:
- Bisacodyl – when sold in concentrations of 5 mg or less per oral dosage unit or 10 mg or less per rectal dosage unit/suppository, in package sizes containing no more than 50 mg of bisacodyl – Unscheduled status (from Schedule III)
- Bisacodyl and its salts [except when sold in concentrations of 5 mg or less per oral dosage unit or 10 mg or less per rectal dosage unit/suppository in package sizes containing no more than 50 mg of bisacodyl] – remains in Schedule III
